[252] revealed that CTX simultaneously expands immunosuppressive inflammatory monocytic myeloid cells (CD11b+Ly6ChiCCR2hi), which inhibit antitumor CD4+ T cell responses via the PD‐1/PD‐L1 axis and promote tumor relapse. The gene discussed is CD274; the disease is neoplasm.